Scholarlink

Background <p>Intestinal capillariasis, caused by <i>Capillaria philippinensis</i>, is an uncommon but potentially fatal parasitic infection associated with the consumption of raw or undercooked freshwater fish. Despite its sporadic occurrence, its clinical severity and diagnostic challenges warrant a comprehensive synthesis of available evidence. This systematic review aimed to summarize the geographic distribution, risk factors, clinical manifestations, diagnostic approaches, and treatment outcomes of human intestinal capillariasis.</p> Methods <p>A systematic search of six electronic databases (PubMed, Scopus, EMBASE, Web of Science, Nursing &amp; Allied Health Premium, Ovid) was conducted to identify studies published between January 2000 and August 2025. Eligible studies included case reports, case series, and observational studies investigating <i>C. philippinensis</i> infection in humans. Study selection was performed independently by two reviewers, while data extraction was conducted by one reviewer using a standardized template and independently verified by a second reviewer, with discrepancies resolved through discussion. Data were extracted and synthesized narratively following the PRISMA 2020 guidelines.</p> Results <p>Thirty-two studies involving 348 patients were included, comprising studies from Asia (25/32), Africa (6/32), and South America (1/32). The burden of intestinal capillariasis was high in symptomatic or high-risk groups (5.0–23.0%) but extremely low (&lt; 0.01%) in community-based or routine screening populations. Consumption of raw or undercooked freshwater fish was consistently identified as the principal risk factor. Clinical features were highly consistent across studies, characterized by chronic watery diarrhea, abdominal pain, weight loss, and peripheral edema. Hypoalbuminemia was the hallmark laboratory abnormality, frequently accompanied by electrolyte disturbances and anemia. Diagnosis relied primarily on stool microscopy, although limited sensitivity often required repeated examinations; histopathology and polymerase chain reaction provided important adjunctive confirmation in selected cases. Co-infections with other intestinal parasites were commonly reported. Treatment with albendazole or mebendazole was generally effective, with comparable outcomes between agents; however, delayed diagnosis was associated with severe complications and occasional mortality.</p> Conclusions <p>Intestinal capillariasis is an underrecognized foodborne infection with a consistent clinical and laboratory profile across study designs. Early diagnosis through repeated stool examination and timely treatment with benzimidazoles is critical to improving outcomes. Strengthening food safety practices and enhancing surveillance are essential to reduce disease burden.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Global distribution, clinical characteristics, and outcomes of human intestinal capillariasis, 2000–2025: a systematic review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月15日

查看全文
  • Jurairat Jongthawin,
  • Kinley Wangdi,
  • Frederick Ramirez Masangkay,
  • Manas Kotepui

摘要

Background

Intestinal capillariasis, caused by Capillaria philippinensis, is an uncommon but potentially fatal parasitic infection associated with the consumption of raw or undercooked freshwater fish. Despite its sporadic occurrence, its clinical severity and diagnostic challenges warrant a comprehensive synthesis of available evidence. This systematic review aimed to summarize the geographic distribution, risk factors, clinical manifestations, diagnostic approaches, and treatment outcomes of human intestinal capillariasis.

Methods

A systematic search of six electronic databases (PubMed, Scopus, EMBASE, Web of Science, Nursing & Allied Health Premium, Ovid) was conducted to identify studies published between January 2000 and August 2025. Eligible studies included case reports, case series, and observational studies investigating C. philippinensis infection in humans. Study selection was performed independently by two reviewers, while data extraction was conducted by one reviewer using a standardized template and independently verified by a second reviewer, with discrepancies resolved through discussion. Data were extracted and synthesized narratively following the PRISMA 2020 guidelines.

Results

Thirty-two studies involving 348 patients were included, comprising studies from Asia (25/32), Africa (6/32), and South America (1/32). The burden of intestinal capillariasis was high in symptomatic or high-risk groups (5.0–23.0%) but extremely low (< 0.01%) in community-based or routine screening populations. Consumption of raw or undercooked freshwater fish was consistently identified as the principal risk factor. Clinical features were highly consistent across studies, characterized by chronic watery diarrhea, abdominal pain, weight loss, and peripheral edema. Hypoalbuminemia was the hallmark laboratory abnormality, frequently accompanied by electrolyte disturbances and anemia. Diagnosis relied primarily on stool microscopy, although limited sensitivity often required repeated examinations; histopathology and polymerase chain reaction provided important adjunctive confirmation in selected cases. Co-infections with other intestinal parasites were commonly reported. Treatment with albendazole or mebendazole was generally effective, with comparable outcomes between agents; however, delayed diagnosis was associated with severe complications and occasional mortality.

Conclusions

Intestinal capillariasis is an underrecognized foodborne infection with a consistent clinical and laboratory profile across study designs. Early diagnosis through repeated stool examination and timely treatment with benzimidazoles is critical to improving outcomes. Strengthening food safety practices and enhancing surveillance are essential to reduce disease burden.

Graphical Abstract